Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

MicroRNAs in the key events of systemic lupus erythematosus pathogenesis

M. Husakova

. 2016 ; 160 (3) : 327-342. [pub] 20160321

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc16028824

Grantová podpora
NT13707 MZ0 CEP - Centrální evidence projektů

BACKGROUND: Small non-coding RNA molecules (miRs) are involved in immune cell maturation and function and might influence immunopathological processes of systemic lupus erythematosus (SLE) pathogenesis. METHODS AND RESULTS: This paper presents the results of a literature search for publications dealing with the relationship between miRs and pathological factors related to SLE such as genetic background, immune dysregulation and gender-associated differences participating in SLE development. In SLE, distinct miRs are differentially expressed in SLE cells of innate and adaptive immunity. The miR-146a and miR-155 genes, among others, interfere with intracellular signalling pathways downstream of toll-like receptors 7 and 9 (TLR- 7, TLR-9) and influences interferon (IFN)-type I synthesis in plasmacytoid dendritic cells. In T and B cells, miR-126, miR-21, miR-146a, miR-155, miR-1246 and others might influence gene expression by epigenetic modifications, support abnormal cytosine release, differentiation of cell subsets, B cell hyperactivity and autoantibody production. Besides, estrogen might up- and downregulate immunologically active miRs, which are potential mediators of hormonal influences in SLE development. Moreover, SLE genetic basis included some polymorphisms of the miR-146a gene, which varies across populations. CONCLUSION: Distinct miRs are differentially expressed in both SLE mice models and human patients and promote autoimmune features of immune processes. MiRs are important molecules modulating susceptibility to SLE as well as its onset, clinical diversity and progression.

000      
00000naa a2200000 a 4500
001      
bmc16028824
003      
CZ-PrNML
005      
20191126131015.0
007      
ta
008      
161005s2016 xr ad f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2016.004 $2 doi
035    __
$a (PubMed)27003314
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Hušáková, Markéta $u Institute of Rheumatology, Prague, Czech Republic $7 xx0143346
245    10
$a MicroRNAs in the key events of systemic lupus erythematosus pathogenesis / $c M. Husakova
520    9_
$a BACKGROUND: Small non-coding RNA molecules (miRs) are involved in immune cell maturation and function and might influence immunopathological processes of systemic lupus erythematosus (SLE) pathogenesis. METHODS AND RESULTS: This paper presents the results of a literature search for publications dealing with the relationship between miRs and pathological factors related to SLE such as genetic background, immune dysregulation and gender-associated differences participating in SLE development. In SLE, distinct miRs are differentially expressed in SLE cells of innate and adaptive immunity. The miR-146a and miR-155 genes, among others, interfere with intracellular signalling pathways downstream of toll-like receptors 7 and 9 (TLR- 7, TLR-9) and influences interferon (IFN)-type I synthesis in plasmacytoid dendritic cells. In T and B cells, miR-126, miR-21, miR-146a, miR-155, miR-1246 and others might influence gene expression by epigenetic modifications, support abnormal cytosine release, differentiation of cell subsets, B cell hyperactivity and autoantibody production. Besides, estrogen might up- and downregulate immunologically active miRs, which are potential mediators of hormonal influences in SLE development. Moreover, SLE genetic basis included some polymorphisms of the miR-146a gene, which varies across populations. CONCLUSION: Distinct miRs are differentially expressed in both SLE mice models and human patients and promote autoimmune features of immune processes. MiRs are important molecules modulating susceptibility to SLE as well as its onset, clinical diversity and progression.
650    _2
$a adaptivní imunita $x fyziologie $7 D056704
650    _2
$a zvířata $7 D000818
650    _2
$a B-lymfocyty $x imunologie $7 D001402
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a estrogeny $x fyziologie $7 D004967
650    _2
$a genetická predispozice k nemoci $7 D020022
650    _2
$a lidé $7 D006801
650    _2
$a přirozená imunita $x fyziologie $7 D007113
650    _2
$a systémový lupus erythematodes $x etiologie $x genetika $x imunologie $7 D008180
650    _2
$a myši $7 D051379
650    _2
$a mikro RNA $x genetika $x fyziologie $7 D035683
650    _2
$a jednonukleotidový polymorfismus $x genetika $7 D020641
650    _2
$a T-lymfocyty $x imunologie $7 D013601
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic $x 1213-8118 $g Roč. 160, č. 3 (2016), s. 327-342
856    41
$u http://biomed.papers.upol.cz/ $y Pubmed
910    __
$a ABA008 $b A 1502 $c 958 $y 4 $z 0
990    __
$a 20161005 $b ABA008
991    __
$a 20191126131301 $b ABA008
999    __
$a ok $b bmc $g 1169620 $s 953456
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 160 $c 3 $d 327-342 $e 20160321 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
GRA    __
$a NT13707 $p MZ0
LZP    __
$b NLK118 $a Pubmed-20161005

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...